Related Experiment Videos

Nosocomial infections in a new medical center, Turkey

B Durmaz1, R Durmaz, B Otlu

  • 1Faculty of Medicine, Department of Clinical Microbiology, Inönü University, Malatya, Turkey.

Insights

A new medical center reported a 2.5% nosocomial infection rate among 10,164 inpatients. Intensive care units and neurology wards showed the highest hospital-acquired infection rates, often involving multidrug-resistant bacteria.

Area of Science:

  • Infectious Diseases
  • Hospital Epidemiology
  • Microbiology

Background:

  • Nosocomial infections pose a significant threat to patient safety in healthcare settings.
  • Understanding infection rates and common pathogens is crucial for developing effective control strategies.
  • New medical centers require early surveillance to establish baseline infection data.

Purpose of the Study:

  • To determine the incidence of nosocomial infections in a newly established medical center.
  • To identify specific hospital services with higher infection rates.
  • To characterize the common microbial agents, particularly multidrug-resistant organisms, associated with these infections.

Main Methods:

  • Retrospective analysis of inpatient data from a 310-bed medical center.
  • Calculation of nosocomial infection rates across different hospital services.
  • Identification and characterization of frequently isolated bacterial pathogens.

Main Results:

  • A total of 255 nosocomial infections were identified in 10,164 inpatients, yielding an overall infection rate of 2.5%.
  • The intensive care unit (12.5%) and neurology (9.5%) services exhibited the highest infection rates.
  • Multiply resistant Enterobacteriaceae and staphylococci were frequently implicated in hospital-acquired infections.

Conclusions:

  • The overall nosocomial infection rate at this new medical center is 2.5%, with significant variations across departments.
  • High infection rates in the ICU and neurology highlight the need for targeted infection control interventions.
  • The prevalence of multidrug-resistant bacteria necessitates robust antimicrobial stewardship and infection prevention programs.

Related Concept Videos